Net cash position down to $4.4m from $4.8m , if it wasn't for the R&D refund it would have been net cash down to $3.2m .
some of next quarter objectives
"Rationalisation of the lending portfolio by restructuring the Company’s balance sheet"
"Improvement of overall margins across the business through the decommissioning of legacy clients and lowmargin programs of work"
- Forums
- ASX - By Stock
- Ann: Quarterly Activities/Appendix 4C Cash Flow Report
SPX
spenda limited
Add to My Watchlist
21.4%
!
0.6¢

Net cash position down to $4.4m from $4.8m , if it wasn't for...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
0.6¢ |
Change
-0.002(21.4%) |
Mkt cap ! $25.38M |
Open | High | Low | Value | Volume |
0.7¢ | 0.7¢ | 0.5¢ | $11.29K | 1.872M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
50 | 26689523 | 0.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.6¢ | 336560 | 4 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
50 | 26689523 | 0.005 |
8 | 15700000 | 0.004 |
8 | 25200000 | 0.003 |
3 | 4500001 | 0.002 |
4 | 8990002 | 0.001 |
Price($) | Vol. | No. |
---|---|---|
0.006 | 336560 | 4 |
0.007 | 17197256 | 21 |
0.008 | 5622738 | 28 |
0.009 | 11710538 | 17 |
0.010 | 1346835 | 6 |
Last trade - 15.59pm 26/06/2025 (20 minute delay) ? |
Featured News
SPX (ASX) Chart |
The Watchlist
PTX
PRESCIENT THERAPEUTICS LIMITED
James McDonnell, CEO
James McDonnell
CEO
Previous Video
Next Video
SPONSORED BY The Market Online